Patients Sponsored 12 Questions with Kim Innes Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry.
Digital Prescribed, but never filled: Why patient access is broken Patient access is no longer just an administrative backroom function; it is a core determinant of health outcomes.
Digital Patient access will not improve without better digital found... Digital health cannot succeed without infrastructure that supports it at every level.
Oncology Early diagnosis means little without timely treatment Early diagnosis only changes outcomes if it is followed by timely treatment.
Oncology CAR-T has a geography problem The gap between what CAR-T can do and who can actually get it is the defining challenge of this field right now.
Sales & Marketing Sponsored 12 Questions with Shauna Lord Shauna Lord recently joined GSK as Business Unit Head Specialty (UK Commercial) to lead the Specialty business in the UK.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
